Shyam S Mohapatra

USPTO Granted Patents = 54 (Patent Applications = 46)

CIPO Patents = 2 (Patent Applications = 3)

EPO Patents = 2 (Patent Applications = 4)

Average Co-Inventor Count = 2.4

ph-index = 7

Forward Citations = 125(Granted Patents)

Forward Citations (Not Self Cited) = 68(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Tampa, FL (US) (2002 - 2024)
Lutz, FL (US) (2011 - 2024)

Company Filing History:

53 out of 1,933

University of South Florida

patents

6 out of 894

The United States Government As Represented by the Department of Veterans Affairs

patents

3 out of 6

Transgenex Nanobiotech Inc.

patents

4. 1 out of 3,687

Johns Hopkins University

patents

5. 1 out of 1

Transgenex Therapeutics, LLC

patent

6. 1 out of 832,843

Other

patents

where one patent can have more than one assignee

Years Active: 2002-2025

Loading Chart...

Areas of Expertise:

Exosomes

Ultrafast-UV Laser

Microparticle Compositions

Tumoroid-on-a-Chip

Nicotinic Receptor Antagonists

Microfluidic Models

Nanoparticle Drug Delivery

Chitosan Nanoparticles

Micro-RNAs

Genetic Adjuvants

Inflammation Modulation

RNA Viral Diseases

54 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12499537 - Systems and methods of deep learning for colorectal polyp screening (2025-12-16),

2. 12453744 - Exosomes isolated from mesenchymal stem cells and uses thereof (2025-10-28),

3. 12447225 - Ultrafast-UV laser integrating cavity mediated inactivation of a pathogen (2025-10-21),

4. 11951152 - Microparticle compositions for controlled delivery of telmisartan and actinomycin D (2024-04-09),

5. 11911481 - Compositions and methods for treating RSV-infections (2024-02-27),

6. 11884906 - 4D-perfused tumoroid-on-a-chip platform for personalized cancer treatment applications (2024-01-30),

7. 11766429 - Nicotinic receptor antagonists and pioglitazone as therapeutic agents for Covid-19 (2023-09-26),

8. 11752220 - Method of delivering genes and drugs to a posterior segment of an eye (2023-09-12),

9. 11685885 - 4D-perfused tumoroid-on-a-chip platform for personalized cancer treatment applications (2023-06-27),

10. 11607426 - Method of targeting oncolytic viruses to tumors (2023-03-21),

11. 11198842 - Microfluidic-coupled in vitro model of the blood-brain barrier (2021-12-14),

12. 11110183 - Method of delivering genes and drugs to a posterior segment of an eye (2021-09-07),

13. 11016062 - System and method of measuring cell viability and growth (2021-05-25),

14. 10813935 - Methods and compositions for treating drug resistance in cancer (2020-10-27),

15. 10675301 - Chitosan oligomer and zinc oxide nanoparticle compositions for treating drug resistant bacteria and biofilm (2020-06-09),

Title: The Innovative Journey of Inventor Shyam S Mohapatra

Introduction: Shyam S Mohapatra, a distinguished inventor based in Lutz, FL (US), has made significant contributions to the field of innovations and inventions.

Latest Patents: Shyam S Mohapatra holds several patents in various areas of technology and healthcare, showcasing his continuous commitment to pioneering advancements.

Career Highlights: With a career spanning decades, Mohapatra has been at the forefront of groundbreaking research, particularly in the fields of biotechnology and medical devices. His innovative solutions have revolutionized the way we approach healthcare challenges.

Collaborations: Throughout his career, Shyam S Mohapatra has collaborated with leading research institutions, universities, and companies to further his inventions and bring them to market. His collaborative spirit has led to the development of cutting-edge technologies with real-world applications.

Conclusion: In conclusion, Shyam S Mohapatra's relentless pursuit of innovation and his dedication to improving lives through his inventions have solidified his position as a prominent figure in the world of inventors. His work continues to inspire future generations of innovators to push the boundaries of what is possible.

This text is generated by artificial intelligence and may not be accurate.